The developmental genetics of congenital heart disease (original) (raw)

• Hoffman, J. I. & Kaplan, S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 39, 1890–1900 (2002).
  Article Google Scholar
• Hoffman, J. I. Incidence of congenital heart disease: II. Prenatal incidence. Pediatr. Cardiol. 16, 155–165 (1995).
  Article CAS Google Scholar
• Miller, S. P. et al. Abnormal brain development in newborns with congenital heart disease. N. Engl. J. Med. 357, 1928–1938 (2007).
  Article ADS CAS Google Scholar
• Pierpont, M. E. et al. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115, 3015–3038 (2007).
  Article Google Scholar
• Jenkins, K. J. et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115, 2995–3014 (2007).
  Article Google Scholar
• Cooper, W. O. et al., Major congenital malformations after first-trimester exposure to ACE inhibitors. N. Engl. J. Med. 354, 2443–2451 (2006).
  Article CAS Google Scholar
• Olson, E. N. Gene regulatory networks in the evolution and development of the heart. Science 313, 1922–1927 (2006).
  Article ADS CAS Google Scholar
• Srivastava, D. Making or breaking the heart: from lineage determination to morphogenesis. Cell 126, 1037–1048 (2006).
  Article CAS Google Scholar
• Buckingham, M., Meilhac, S. & Zaffran, S. Building the mammalian heart from two sources of myocardial cells. Nature Rev. Genet. 6, 826–835 (2005). The concept of the SHF is outlined clearly in this review.
  Article CAS Google Scholar
• Kattman, S. J., Huber, T. L. & Keller, G. M. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell 11, 723–732 (2006).
  Article CAS Google Scholar
• Wu, S. M. et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 127, 1137–1150 (2006).
  Article CAS Google Scholar
• Moretti, A. et al. Multipotent embryonic ISL1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127, 1151–1165 (2006). Refs 10–12 show that a single committed progenitor gives rise to all three cardiac cell types.
  Article CAS Google Scholar
• Tzahor, E. Wnt/β-catenin signaling and cardiogenesis: timing does matter. Dev. Cell 13, 10–13 (2007).
  Article CAS Google Scholar
• Schoenebeck, J. J., Keegan, B. R. & Yelon, D. Vessel and blood specification override cardiac potential in anterior mesoderm. Dev. Cell 13, 254–267 (2007).
  Article CAS Google Scholar
• Keegan, B. R., Feldman, J. L., Begemann, G., Ingham, P. W. & Yelon, D. Retinoic acid signaling restricts the cardiac progenitor pool. Science 307, 247–249 (2005).
  Article ADS CAS Google Scholar
• Prall, O. W. et al. An Nkx2-5/Bmp2/Smad1 negative feedback loop controls second heart field progenitor specification and proliferation. Cell 128, 947–959 (2007).
  Article CAS Google Scholar
• Lickert, H. et al. Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 432, 107–112 (2004).
  Article ADS CAS Google Scholar
• Gottlieb, P. D. et al. Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis. Nature Genet. 31, 25–32 (2002).
  Article CAS Google Scholar
• Montgomery, R. L. et al. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev. 21, 1790–1802 (2007).
  Article CAS Google Scholar
• Basson, C. T. et al. Mutations in human TBX5 cause limb and cardiac malformation in Holt–Oram syndrome. Nature Genet. 15, 30–35 (1997).
  Article CAS Google Scholar
• Li, Q. Y. et al. Holt–Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nature Genet. 15, 21–29 (1997).
  Article Google Scholar
• Schott, J.-J. et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5 . Science 281, 108–111 (1998).This paper describes the first single-gene defect identified in non-syndromic congenital heart disease and directly links an important developmental regulator to disease.
  Article ADS CAS Google Scholar
• Benson, D. W. et al. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J. Clin. Invest. 104, 1567–1573 (1999).
  Article CAS Google Scholar
• Biben, C. et al. Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. Circ. Res. 87, 888–895 (2000).
  Article CAS Google Scholar
• Bruneau, B. G. et al. A murine model of Holt–Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106, 709–721 (2001).
  Article CAS Google Scholar
• Hiroi, Y. et al. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nature Genet. 28, 276–280 (2001).
  Article CAS Google Scholar
• Garg, V. et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424, 443–447 (2003). Refs 25–27 show that interactions between cardiac transcription factors are an important mechanism for congenital heart diseases.
  Article ADS CAS Google Scholar
• Lindsay, E. A. et al. Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410, 97–101 (2001).
  Article ADS CAS Google Scholar
• Merscher, S. et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104, 619–629 (2001). Refs 28 and 29 deployed mouse genome engineering to pinpoint Tbx1 as a major causative gene in the 22q11 microdeletion syndrome critical region.
  Article CAS Google Scholar
• Yagi, H. et al. Role of TBX1 in human del22q11.2 syndrome. Lancet 362, 1366–1373 (2003).
  Article CAS Google Scholar
• Hu, T. et al. Tbx1 regulates fibroblast growth factors in the anterior heart field through a reinforcing autoregulatory loop involving forkhead transcription factors. Development 131, 5491–5502 (2004).
  Article CAS Google Scholar
• Xu, H. et al. Tbx1 has a dual role in the morphogenesis of the cardiac outflow tract. Development 131, 3217–3227 (2004).
  Article CAS Google Scholar
• Guris, D. L., Duester, G., Papaioannou, V. E. & Imamoto, A. Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome. Dev. Cell 10, 81–92 (2006).
  Article CAS Google Scholar
• Moon, A. M. et al. Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes. Dev. Cell 10, 71–80 (2006).
  Article CAS Google Scholar
• Al-Baradie, R. et al. Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family. Am. J. Hum. Genet. 71, 1195–1199 (2002).
  Article CAS Google Scholar
• Kohlhase, J. et al. Okihiro syndrome is caused by SALL4 mutations. Hum. Mol. Genet. 11, 2979–2987 (2002).
  Article CAS Google Scholar
• Kirk, E. P. et al. Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am. J. Hum. Genet. 81, 280–291 (2007).
  Article CAS Google Scholar
• Koshiba-Takeuchi, K. et al. Cooperative and antagonistic interactions between Sall4 and Tbx5 pattern the mouse limb and heart. Nature Genet. 38, 175–183 (2006).
  Article CAS Google Scholar
• Satoda, M. et al. Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nature Genet. 25, 42–46 (2000).
  Article CAS Google Scholar
• Muncke, N. et al. Missense mutations and gene interruption in PROSIT240, a novel _TRAP240_-like gene, in patients with congenital heart defect (transposition of the great arteries). Circulation 108, 2843–2850 (2003).
  Article CAS Google Scholar
• Hove, J. R. et al. Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis. Nature 421, 172–177 (2003).
  Article ADS CAS Google Scholar
• Auman, H. J. et al. Functional modulation of cardiac form through regionally confined cell shape changes. PLoS Biol. 5, e53 (2007).
  Article Google Scholar
• Yashiro, K., Shiratori, H. & Hamada, H. Haemodynamics determined by a genetic programme govern asymmetric development of the aortic arch. Nature 450, 285–288 (2007). This paper links genetic programming and haemodynamics in the development of congenital heart diseases in a mouse model.
  Article ADS CAS Google Scholar
• Ching, Y. H. et al. Mutation in myosin heavy chain 6 causes atrial septal defect. Nature Genet. 37, 423–428 (2005).
  Article CAS Google Scholar
• Barnett, J. V. & Desgrosellier, J. S. Early events in valvulogenesis: a signaling perspective. Birth Defects Res. C Embryo Today 69, 58–72 (2003).
  Article CAS Google Scholar
• Timmerman, L. A. et al. Notch promotes epithelial–mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 18, 99–115 (2004).
  Article CAS Google Scholar
• Garg, V. et al. Mutations in NOTCH1 cause aortic valve disease. Nature 437, 270–274 (2005).
  Article ADS CAS Google Scholar
• Li, L. et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nature Genet. 16, 243–251 (1997).
  Article CAS Google Scholar
• Oda, T. et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nature Genet. 16, 235–242 (1997).
  Article CAS Google Scholar
• McDaniell, R. et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am. J. Hum. Genet. 79, 169–173 (2006).
  Article CAS Google Scholar
• Gelb, B. D. & Tartaglia, M. Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction. Hum. Mol. Genet. 15 (Spec. No. 2), R220–R226 (2006).
  Article CAS Google Scholar
• Pandit, B. et al. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nature Genet. 39, 1007–1012 (2007).
  Article CAS Google Scholar
• Razzaque, M. A. et al. Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nature Genet. 39, 1013–1017 (2007).
  Article CAS Google Scholar
• Roberts, A. E. et al. Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nature Genet. 39, 70–74 (2007).
  Article CAS Google Scholar
• Tartaglia, M. et al. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nature Genet. 39, 75–79 (2007).
  Article CAS Google Scholar
• Araki, T. et al. Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation. Nature Med. 10, 849–857 (2004).
  Article CAS Google Scholar
• Ambros, V. The functions of animal microRNAs. Nature 431, 350–355 (2004).
  Article ADS CAS Google Scholar
• van Rooij, E. & Olson, E. N. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J. Clin. Invest. 117, 2369–2376 (2007).
  Article CAS Google Scholar
• Zhao, Y., Samal, E. & Srivastava, D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436, 214–220 (2005).
  Article ADS CAS Google Scholar
• Zhao, Y. et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129, 303–317 (2007). This paper demonstrates the importance of a cardiac miRNA in heart development, suggesting a possible new disease mechanism.
  Article CAS Google Scholar
• Warnes, C. A. The adult with congenital heart disease: born to be bad? J. Am. Coll. Cardiol. 46, 1–8 (2005).
  Article Google Scholar
• Bisping, E. et al. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc. Natl Acad. Sci. USA 103, 14471–14476 (2006).
  Article ADS CAS Google Scholar
• Pashmforoush, M. et al. Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 117, 373–386 (2004).
  Article CAS Google Scholar
• Zhou, W. et al. Modulation of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family-mediated transcriptional activation of TGFβ2. Nature Genet. 39, 1225–1234 (2007).
  Article CAS Google Scholar
• Takeuchi, J. K. et al. Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motoneuron development. Development 132, 2463–2474 (2005).
  Article CAS Google Scholar
• Stennard, F. A. et al. Murine T-box transcription factor Tbx20 acts as a repressor during heart development, and is essential for adult heart integrity, function and adaptation. Development 132, 2451–2462 (2005).
  Article CAS Google Scholar
• Jiao, K. et al. An essential role of Bmp4 in the atrioventricular septation of the mouse heart. Genes Dev. 17, 2362–2367 (2003).
  Article CAS Google Scholar
• Rajagopal, S. K. et al. Spectrum of heart disease associated with murine and human GATA4 mutation. J. Mol. Cell. Cardiol. 43, 677–685 (2007).
  Article CAS Google Scholar